Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?6.5 WB, SLActive? 8mm, RXD: medical device reports filed with FDA

1,883 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,883
device reports naming the brand
0% of all MAUDE reports · about 266 a year
379
reports, 12 months to August 2026
339 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,883 medical device reports received by FDA name the brand "BLX ?6.5 WB, SLActive? 8mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

379 reports arrived in the 12 months to August 2026, up 12% from 339 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (50.9%), loss of osseointegration (19.6%) and difficult to insert (3%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03467Sep 2021: 10Oct 2021: 17Nov 2021: 28Dec 2021: 152022Jan 2022: 23Feb 2022: 16Mar 2022: 11Apr 2022: 31May 2022: 26Jun 2022: 22Jul 2022: 24Aug 2022: 17Sep 2022: 15Oct 2022: 22Nov 2022: 32Dec 2022: 182023Jan 2023: 19Feb 2023: 22Mar 2023: 24Apr 2023: 24May 2023: 21Jun 2023: 34Jul 2023: 21Aug 2023: 38Sep 2023: 18Oct 2023: 19Nov 2023: 32Dec 2023: 282024Jan 2024: 18Feb 2024: 33Mar 2024: 18Apr 2024: 42May 2024: 45Jun 2024: 31Jul 2024: 27Aug 2024: 45Sep 2024: 31Oct 2024: 17Nov 2024: 28Dec 2024: 322025Jan 2025: 24Feb 2025: 18Mar 2025: 37Apr 2025: 21May 2025: 0Jun 2025: 67Jul 2025: 34Aug 2025: 30Sep 2025: 29Oct 2025: 33Nov 2025: 24Dec 2025: 462026Jan 2026: 34Feb 2026: 38Mar 2026: 39Apr 2026: 28May 2026: 28Jun 2026: 23Jul 2026: 30Aug 2026: 27

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01843672019: 2720192020: 10120202021: 22120212022: 25720222023: 30020232024: 36720242025: 36320252026: 2472026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,883
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report66%1,242
Voluntary report0%0
User facility report0%0
Distributor report34%641
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate95850.9%62.8%
Loss of osseointegration37019.6%22.4%
Difficult to insertthe device was hard to insert563%0.4%
Separation failure110.6%0.1%
Fracturea broken bone70.4%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis59831.8%
Painpain, site not specified28915.3%
Inflammationinflammation864.6%
Tissue damage784.1%
Hemorrhage/blood loss/bleeding462.4%
Swelling/ edema361.9%
Abscessa collection of pus301.6%
Hyperresponsive to stimuli251.3%
Sinus perforation231.2%
Hypersensitivity/allergic reaction191%
Fistula140.7%
Failure of implant120.6%
Numbnessnumbness80.4%
Inadequate osseointegration60.3%
Increased sensitivity20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?6.5 WB, SLActive? 8mm, RXDProduct code DZEAll MAUDE reports
Reports1,8833,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer66%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?6.5 WB, SLActive? 8mm, RXD reports

How many FDA reports name BLX ?6.5 WB, SLActive? 8mm, RXD?

1,883 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 379 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (50.9%), loss of osseointegration (19.6%), difficult to insert (3%), separation failure (0.6%) and fracture (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (66%) and distributor reports (34%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?6.5 WB, SLActive? 8mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.